📝 SummarXiv

Abstract

Gene enhancers control when and where genes switch on, yet their sequence diversity and tissue specificity make them hard to pinpoint in colorectal cancer. We take a sequence-only route and fine-tune DNABERT-2, a transformer genomic language model that uses byte-pair encoding to learn variable-length tokens from DNA. Using assays curated via the Johnston Cancer Research Centre at Queen's University Belfast, we assembled a balanced corpus of 2.34 million 1 kb enhancer sequences, applied summit-centered extraction and rigorous de-duplication including reverse-complement collapse, and split the data stratified by class. With a 4096-term vocabulary and a 232-token context chosen empirically, the DNABERT-2-117M classifier was trained with Optuna-tuned hyperparameters and evaluated on 350742 held-out sequences. The model reached PR-AUC 0.759, ROC-AUC 0.743, and best F1 0.704 at an optimized threshold (0.359), with recall 0.835 and precision 0.609. Against a CNN-based EnhancerNet trained on the same data, DNABERT-2 delivered stronger threshold-independent ranking and higher recall, although point accuracy was lower. To our knowledge, this is the first study to apply a second-generation genomic language model with BPE tokenization to enhancer classification in colorectal cancer, demonstrating the feasibility of capturing tumor-associated regulatory signals directly from DNA sequence alone. Overall, our results show that transformer-based genomic models can move beyond motif-level encodings toward holistic classification of regulatory elements, offering a novel path for cancer genomics. Next steps will focus on improving precision, exploring hybrid CNN-transformer designs, and validating across independent datasets to strengthen real-world utility.